| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/2004 | WO2004078778A2 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF |
| 09/16/2004 | WO2004078777A2 Dipeptidyl-peptidase protected proteins |
| 09/16/2004 | WO2004078776A2 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 09/16/2004 | WO2004078775A2 Intracellular signaling-induced ret-independent gdnf receptor-effected morphological changes |
| 09/16/2004 | WO2004078208A1 MEDICINAL USE OF MIP-3α INHIBITOR AND METHOD OF SCREENING BRAIN/NERVE CELL PROTECTIVE AGENT |
| 09/16/2004 | WO2004078205A1 Targeting a protein prc1 for the treatment of pancreatic cancer |
| 09/16/2004 | WO2004078203A2 Infectious bronchitis virus with an altered spike gene |
| 09/16/2004 | WO2004078195A1 Agent for converting intestinal cell into insulin-producing cell and remedy for diabetes |
| 09/16/2004 | WO2004078135A2 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004078124A2 Methods and compositions involving mda-7 |
| 09/16/2004 | WO2004078123A2 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 09/16/2004 | WO2004078112A2 Apoptosis inducing gene |
| 09/16/2004 | WO2004078098A2 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
| 09/16/2004 | WO2004078097A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 09/16/2004 | WO2004077942A2 Inducible prostate cancer model |
| 09/16/2004 | WO2004072225A3 Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi |
| 09/16/2004 | WO2004072112A3 A method for formulating mhc-like molecules for long time storage |
| 09/16/2004 | WO2004069140A3 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 09/16/2004 | WO2004065406A3 Rantes-derived peptides with anti-hiv activity |
| 09/16/2004 | WO2004064709A3 Thrombolytic agent |
| 09/16/2004 | WO2004063719A3 Method to form a protein microarray system |
| 09/16/2004 | WO2004062556A3 Methods for preventing and treating alzheimer’s disease (ad) |
| 09/16/2004 | WO2004061116A3 Compositions and methods for hydroxilating epothilones |
| 09/16/2004 | WO2004058818A3 Spliced variants of lgr6 |
| 09/16/2004 | WO2004058798A3 Antimicrobial peptides |
| 09/16/2004 | WO2004055048A3 Chimeric alpha q-gustducin g-proteins |
| 09/16/2004 | WO2004053120A3 Regulatory elements in the 5' region of the vr1 gene |
| 09/16/2004 | WO2004053094A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/16/2004 | WO2004052278A3 Escape mutants of newcastle disease virus as marker vaccines |
| 09/16/2004 | WO2004050880B1 Insecticidal agent |
| 09/16/2004 | WO2004050706A3 Regulatory t-cells |
| 09/16/2004 | WO2004050679A3 Mutant glycoproteins |
| 09/16/2004 | WO2004048535A3 Sugar and lipid metabolism regulators in plants v |
| 09/16/2004 | WO2004048409A3 Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | WO2004046376A3 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 09/16/2004 | WO2004046338A3 Use of hmgb polypeptides for increasing immune responses |
| 09/16/2004 | WO2004046180A3 Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis inducing factor mutant add70 |
| 09/16/2004 | WO2004042031A3 Safer attenuated virus vaccines with missing or diminished latency of infection |
| 09/16/2004 | WO2004041205A3 Ha4, a new osteoblast- and chondrocyte-specific small secreted peptide, compositions and methods of use |
| 09/16/2004 | WO2004038021A8 Gpr54 knock-out mammals and screening methods using them |
| 09/16/2004 | WO2004032973A3 Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases |
| 09/16/2004 | WO2004026905A3 Transporter/channel proteins |
| 09/16/2004 | WO2004025263A3 Protein and peptide expression for passive immunity |
| 09/16/2004 | WO2004022710A3 Methods of modulating cell death based on the bit1/aes regulatory pathway |
| 09/16/2004 | WO2004022577A3 Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 09/16/2004 | WO2004020606A3 Method of resisting osteoclast formation |
| 09/16/2004 | WO2004016230A3 Identification of the endothelial receptor for the angiostatin kringle-5 |
| 09/16/2004 | WO2004009791A3 Modulators of b-lymphocyte activation, myosin-1f compositions and methods of use |
| 09/16/2004 | WO2003106615A3 Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| 09/16/2004 | WO2003105665A3 Epstein-barr virus-specific immunization |
| 09/16/2004 | WO2003099848A3 Method for universal enzymatic production of bioactive peptides |
| 09/16/2004 | WO2003099778A3 Inhibitors of proteins from the rho-gef family |
| 09/16/2004 | WO2003096974A3 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION |
| 09/16/2004 | WO2003089603A3 Cytokine receptor |
| 09/16/2004 | WO2003083079A3 Bone generation by gene therapy |
| 09/16/2004 | WO2003083041A8 Cripto-specific antibodies |
| 09/16/2004 | WO2003082900A3 Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures |
| 09/16/2004 | WO2003074657A3 Cold shock inducible expression and production of heterologous polypeptides |
| 09/16/2004 | WO2003074128A3 Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds |
| 09/16/2004 | WO2003070746A3 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua |
| 09/16/2004 | WO2003053457A8 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003040307A3 Heteromultimeric tnf ligand family members |
| 09/16/2004 | WO2003040168A3 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype |
| 09/16/2004 | WO2003018744A3 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 09/16/2004 | WO2003013227A3 Yield-related polynucleotides and polypeptides in plants |
| 09/16/2004 | WO2002100827A3 Method for increasing the survival of dopamine secreting cells |
| 09/16/2004 | WO2002094198A9 Modulation of cell division by an early mitotic inhibitor protein |
| 09/16/2004 | WO2002077170A3 Expansin protein and polynucleotides and methods of use |
| 09/16/2004 | WO2002069691A3 Immunogenic hiv peptides for use as reagents and vaccines |
| 09/16/2004 | WO2002050097A3 Anti-allergic complex molecules |
| 09/16/2004 | US20040181830 for improved yield, drought/stress tolerance using genetically engineered cotton polypeptide |
| 09/16/2004 | US20040181828 Plant genes encoding DR1 and DRAP1, a global repressor complex of transcription |
| 09/16/2004 | US20040181826 for for producing flavonoids using transgenic plants transformed by a genetically engineered vector |
| 09/16/2004 | US20040181825 Prevention of Bt resistance development |
| 09/16/2004 | US20040181824 for modulating, in a transgenic plant, expression of the nucleic acids and for increasing transformation efficiency; genetic engineering |
| 09/16/2004 | US20040181820 Nucleic acids for transforming fish cells and methods for their use |
| 09/16/2004 | US20040181143 Imaging of a region in a scattering medium |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181046 Comprises nucleotide sequences coding fungal protein for diagnosis, prevetion and treatment of respiratory system disorders |
| 09/16/2004 | US20040181044 for bone marrow recovery in treatment of radiation, chemical, or chemotherapeutic induced bone marrow aplasia or myelosuppression |
| 09/16/2004 | US20040181041 Fusion protein capable of inducing programmed cell death for use in treatment cell proliferative diseases and infection |
| 09/16/2004 | US20040181040 Mammalian cytokine-like polypeptide-10 |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040181036 Mutant forms of cholera holotoxin as an adjuvant |
| 09/16/2004 | US20040181035 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 09/16/2004 | US20040181034 Multimeric Apo A-I agonist compounds |
| 09/16/2004 | US20040181033 Binding agents which inhibit myostatin |
| 09/16/2004 | US20040181032 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 09/16/2004 | US20040180836 Blocking peptide for inflammatory cell secretion |
| 09/16/2004 | US20040180831 Efficiently lower serum calcium levels, bioavailability; chymotrypsin and/or trypsin degradation resistance; bone disorders |
| 09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
| 09/16/2004 | US20040180826 Novel receptor that causes cell death |
| 09/16/2004 | US20040180825 Semaphorin polypeptides |
| 09/16/2004 | US20040180823 Peptides, peptidomimetics; promoting programmed cell death; neural regeneration |
| 09/16/2004 | US20040180819 Characterization of a membrane estrogen receptor |
| 09/16/2004 | US20040180811 Compositions involving M-RIP, and related methods for screening for anti-hypertensive agents, and uses thereof |